Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06780397
What this trial is testing

Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

Who this might be right for
Melanoma, Stage IIMelanoma Stage IIIMelanoma Stage IV
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Early research (Phase 1)Study completedNCT00112242
What this trial is testing

Immunotherapy of Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 39
Testing effectiveness (Phase 2)Study completedNCT00022464
What this trial is testing

CCI-779 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Testing effectiveness (Phase 2)Study completedNCT02731729
What this trial is testing

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

Who this might be right for
Melanoma
Parker Institute for Cancer Immunotherapy 20
Testing effectiveness (Phase 2)Temporarily pausedNCT00278122
What this trial is testing

Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
University of Virginia 42
Testing effectiveness (Phase 2)Study completedNCT00861913
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT04059224
What this trial is testing

TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma

Who this might be right for
Stage IV MelanomaStage III Melanoma
Universitair Ziekenhuis Brussel 45
Very early researchStudy completedNCT00470379
What this trial is testing

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

Who this might be right for
Melanoma (Skin)
Mayo Clinic 30
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT00002860
What this trial is testing

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 77
Testing effectiveness (Phase 2)Study completedNCT01127451
What this trial is testing

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Who this might be right for
Stage IIIC MelanomaStage IV Melanoma
Eisai Inc. 75
Early research (Phase 1)Study completedNCT01462773
What this trial is testing

Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma

Who this might be right for
Melanoma
Ohio State University Comprehensive Cancer Center 16
Not applicableStudy completedNCT05102773
What this trial is testing

The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage IV Cutaneous Melanoma AJCC v8
Ohio State University Comprehensive Cancer Center 88
Not applicableStudy completedNCT03879395
What this trial is testing

Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

Who this might be right for
Melanoma Stage IvMelanoma MetastaticAbdominal Tumor
Vastra Gotaland Region 15
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT00847106
What this trial is testing

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 15
Early research (Phase 1)Ended earlyNCT00585000
What this trial is testing

Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma

Who this might be right for
Melanoma
AstraZeneca 49
Next Page